Κυριακή 6 Μαΐου 2018

Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic‐phase chronic myeloid leukemia

Cancer, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2rpy8ZJ
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου